With these changes, Musunuru predicts that the team will be able to shrink the time needed to produce a therapy from six months to three ... would need to find a company to sponsor the application.

A promising “two-in-one” experimental drug could tackle both type 2 diabetes and heart disease by slashing cholesterol and ...

Researchers at the University Hospital Bonn (UKB) and the University of Bonn have discovered how a small, naturally occurring ...

People with type 1 diabetes achieved significantly better long-term blood glucose when their levels were monitored by ...